| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/12/1989 | US4865848 Skin permeation enhancer compositions using sucrose esters |
| 09/12/1989 | US4865844 Antimicrobial organosilane quaternary ammonium salt |
| 09/12/1989 | US4865789 Method for making porous structures |
| 09/12/1989 | CA1259450A1 Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency |
| 09/08/1989 | WO1989008127A1 Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone |
| 09/08/1989 | WO1989008119A1 High molecular weight prodrug derivatives of anti-inflammatory drugs |
| 09/08/1989 | WO1989007951A1 Transdermal estradiol delivery system |
| 09/08/1989 | WO1989007945A1 Human relaxin formulation |
| 09/08/1989 | WO1989007944A1 Device for site directed neovascularization and method for same |
| 09/08/1989 | WO1989007941A1 Water-soluble complexes of pharmaceuticals |
| 09/08/1989 | WO1989007936A1 Integrity protected gelatin |
| 09/06/1989 | EP0331489A2 Acne treatment |
| 09/06/1989 | EP0331471A1 High molecular weight prodrug derivatives of antiinflammatory drugs |
| 09/06/1989 | EP0331391A1 Method for reducing sensitization or irritation in transdermal drug delivery and means therefor |
| 09/06/1989 | EP0331385A2 Aqueous suspension of sucralfate |
| 09/06/1989 | EP0331382A2 Transdermal flux enhancing compositions |
| 09/06/1989 | EP0331092A2 Alpha-amino-carboxylic-acid derivatives, their preparation and use |
| 09/06/1989 | EP0331034A2 Functionally specific antibodies |
| 09/06/1989 | EP0330665A1 Hydrosoluble ubidecarenones derivatives and their preparation |
| 09/06/1989 | CN1035311A (poly) silicone disperser dehydrated crosslinking to elastic body |
| 09/06/1989 | CN1035242A Pharmaceutical composition for 4-aroylimidazol-2-ones |
| 09/06/1989 | CN1035241A Stabilized ascorbic acid powder |
| 09/05/1989 | US4863970 Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols |
| 09/05/1989 | US4863964 Method for the stabilization of deferoxamine to chelate free ions in physiological fluid |
| 09/05/1989 | US4863952 Method of promoting percutaneous drug absorption with 2-pyrrolidin-2-one 5-carboxylic acids and esters thereof |
| 09/05/1989 | US4863898 Amino acid chelated compositions for delivery to specific biological tissue sites |
| 09/05/1989 | US4863896 Diabetic control by combined insulin forms |
| 09/05/1989 | US4863738 Transdermal drug delivery |
| 09/05/1989 | US4863735 Biodegradable polymeric drug delivery system with adjuvant activity |
| 09/05/1989 | US4863724 Anti-diabetic pharmaceutical compositions and the preparation thereof |
| 09/05/1989 | US4863713 Diagnosis of tumors |
| 08/30/1989 | EP0330511A2 Stabilization of 13,14-dihydro-15-ketoprostaglandins |
| 08/30/1989 | EP0330284A2 Process for the preparation of a pharmaceutical granulate |
| 08/30/1989 | EP0330254A1 Alkyl (3-methylthio)-butyrates, as well as flavour compositions and flavoured foodstuffs and stimulants containing one or more of these compounds as flavour component |
| 08/30/1989 | EP0330201A2 Method of enhancing the effect of cytotoxic agents |
| 08/30/1989 | EP0330180A1 Polylactic acid type microspheres containing physiologically active substance and process for preparing the same |
| 08/30/1989 | EP0329977A2 A xylitol-based binding and diluting agent and a process for the production thereof |
| 08/30/1989 | EP0329778A1 Molecular decoyants and methods of use thereof |
| 08/30/1989 | EP0329737A1 Tri-aza macrocycles and metal complexes thereof |
| 08/30/1989 | EP0329730A1 Encapsulation by entrapment within starch matrix |
| 08/30/1989 | EP0329669A1 Compositions comprising n,n-dialkylalkanamides and their uses |
| 08/29/1989 | US4861797 Liquid ibuprofen compositions and methods of making them |
| 08/29/1989 | US4861786 Composition for a stable vein compatible injectable solution of torasemide process for the preparation and method of use |
| 08/29/1989 | US4861764 Percutaneous absorption enhancers, compositions containing same and method of use |
| 08/29/1989 | US4861760 Ophthalmological composition of the type which undergoes liquid-gel phase transition |
| 08/29/1989 | US4861599 Galenic formulations for oral use of rhein derivatives with delayed release for therapeutical use |
| 08/29/1989 | US4861598 Higher aliphatic alcohol and acrylic resin |
| 08/29/1989 | US4861588 Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 08/29/1989 | US4861586 Medicament enveloped by carrier of hardened fat, shape stabilizer, and lure |
| 08/29/1989 | US4861581 Detection of necrotic malignant tissue and associated therapy |
| 08/29/1989 | US4861580 Composition using salt form of organic acid derivative of alpha-tocopheral |
| 08/29/1989 | US4861579 Suppression of B-lymphocytes in mammals by administration of anti-B-lymphocyte antibodies |
| 08/29/1989 | US4861380 Composition |
| 08/24/1989 | WO1989007619A1 Hydrophilic carboxy polyurethanes |
| 08/24/1989 | WO1989007601A1 Antigens against autoimmune diseases |
| 08/24/1989 | WO1989007456A1 Method of preparing a metal-radionuclide-labelled protein |
| 08/24/1989 | WO1989007455A1 Crosslinked hydrophilic copolymer for medical and paramedical use |
| 08/24/1989 | WO1989007444A1 Stabilized heparin solution |
| 08/24/1989 | WO1989007439A1 Process for regulating the absorption rate of drugs and a pharmaceutical formulation |
| 08/24/1989 | WO1989007436A1 Minoxidil gel |
| 08/24/1989 | WO1989006974A3 T-cell epitope as carriers molecule for conjugate vaccines |
| 08/24/1989 | DE3804285A1 Adhesive wax and method for use for bleeding and inflammation of the marginal periodontium, in particular gingivitis and periodontitis |
| 08/23/1989 | EP0329460A2 Stabilised macrolide compositions |
| 08/23/1989 | EP0329185A2 Alteration of pharmacokinetics of proteins by charge modification |
| 08/23/1989 | EP0329184A2 Antimers and antimeric conjugation |
| 08/23/1989 | EP0328862A1 A stabilizing agent and an injectable composition containing the same |
| 08/23/1989 | EP0328589A1 Tetra-aza macrocycles and metal complexes thereof |
| 08/22/1989 | US4859709 Liquid absorbed on silica or silicate; free-flowing powder |
| 08/22/1989 | US4859704 Water soluble ibuprofen compositions and methods of making them |
| 08/22/1989 | US4859696 Precutaneous absorption accelerator and preparation containing same |
| 08/22/1989 | US4859470 Dosage form for delivering diltiazem |
| 08/22/1989 | US4859467 Sustained release fluoride composition |
| 08/22/1989 | US4859462 Polymer-treated ion exchange resins |
| 08/22/1989 | US4859461 Coatable ion exchange resins |
| 08/22/1989 | US4859449 Modified antibodies for enhanced hepatocyte clearance |
| 08/22/1989 | CA1258639A1 Dentifrice containing stabilized enzyme |
| 08/22/1989 | CA1258629A1 Stable erythropoietin preparation and process for formulating the same |
| 08/22/1989 | CA1258628A1 Method and composition for preventing the adsorption of a medicine |
| 08/16/1989 | EP0328389A2 Compostions for treating intracranial tumors |
| 08/16/1989 | EP0328355A2 Emulsion compositions including amphipathic emulsifying agents |
| 08/16/1989 | EP0328147A2 Anthracycline immunoconjugates having a novel linker and methods for their production |
| 08/16/1989 | EP0327756A2 Pharmaceutical compositions comprising a calcitonin and a glycyrrhizinate as absorption enhancer |
| 08/16/1989 | CN1034726A Stabilizing agent and injectable composition containing same |
| 08/16/1989 | CN1034670A Process for stabilizing cephalosporins derivatives by drying them with stabiliser and stability composition containing cephalosporins derivatives |
| 08/15/1989 | US4857554 Ointment containing ursolic acid and oleanolic acid in vaseline/lanolin carrier |
| 08/15/1989 | US4857552 Degradable esmolol hydrochloride for cardiovascular disorders; short action, shelf life |
| 08/15/1989 | US4857505 Sustained release compositions for parenteral administration and their use |
| 08/15/1989 | US4857358 Powdery compound emulisifier and its production |
| 08/15/1989 | US4857336 Oral therapeutic system having systemic action |
| 08/15/1989 | US4857335 Active ingredient-polymer complex |
| 08/15/1989 | US4857331 Pectin-algin gel network |
| 08/15/1989 | US4857320 Method of enhancing the solubility of tissue plasminogen activator |
| 08/15/1989 | US4857311 Polyanhydrides with improved hydrolytic degradation properties |
| 08/15/1989 | US4857310 Skin moisturizing, hair conditioner |
| 08/15/1989 | US4857302 Solubilized benzoyl peroxide and cosmetic solution including solubilized benzoyl peroxide |
| 08/15/1989 | CA1258427A1 Process for the preparation of an aqueous insulin formulation which has been stabilized towards mechanical stresses, and its use |
| 08/10/1989 | WO1989007269A1 Method for the preparation of antibody-fragment conjugates |
| 08/10/1989 | WO1989007268A1 Monoclonal antibody specific to a novel mucin-like glycoprotein surface antigen on human carcinoma cells |
| 08/10/1989 | WO1989007114A1 Novel and improved antibodies for site specific attachment of compounds |
| 08/10/1989 | WO1989006976A1 Method of drying macromolecules |